Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4594446

DOTINURAD
🧪 Phase III
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase III
O=C(c1cc(Cl)c(O)c(Cl)c1)N1CS(=O)(=O)c2ccccc21

Basic Information

ChEMBL ID CHEMBL4594446
Name DOTINURAD
Phase Phase III
Structure Type MOL
InChI Key VOFLAIHEELWYGO-UHFFFAOYSA-N

Known Names

Dotinurad Fyu-981
5
Targets
7
Activities
1
Assay Types
8
PK Parameters
19
Publications
2
Known Names
3
Indications
1
Mechanisms

Molecular Properties

358.2
MW (Da)
3.09
ALogP
4
HBA
1
HBD
74.7
PSA (Ų)
0.85
QED
0
Ro5 Violations
1
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Achiral
USAN Stem -inurad

Extended Properties

Molecular Formula C14H9Cl2NO4S
MW 358.20
Aromatic Rings 2
Heavy Atoms 22
NP-Likeness -0.99

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Solute carrier family 22 member 12 inhibitor INHIBITOR Solute carrier family 22 member 12

Indications

Gout Hyperuricemia Renal Insufficiency

Activity Summary

IC50 7 meas. best 7.43

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Broad substrate specificity ATP-binding cassette transporter ABCG2
CHEMBL5393
IC50 7.43 7.43 37.2 1
Solute carrier family 22 member 12
CHEMBL6120
IC50 7.43 6.6667 37.2 3
Unchecked
CHEMBL612545
IC50 5.44 5.44 3600.0 1
Cytochrome P450 2C9
CHEMBL3397
IC50 5.24 5.24 5700.0 1
ADMET
CHEMBL612558
IC50 4.57 4.57 27000.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 5744.7 ng.hr.mL-1 Rattus norvegicus
AUC 6619.5 ng.hr.mL-1 Rattus norvegicus
AUC 108550.0 ng.hr.mL-1 Cebus
Cmax 25516.47 nM Rattus norvegicus
Cmax 3031.83 nM Rattus norvegicus
Cmax 6702.96 nM Rattus norvegicus
Cmax 25516.47 nM Rattus norvegicus
F 86.8 % Rattus norvegicus

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
33062187 10.1021/acsmedchemlett.0c00176 ADMET 10
33062187 10.1021/acsmedchemlett.0c00176 Solute carrier family 22 member 12 4
34213340 10.1021/acs.jmedchem.1c00790 ADMET 3
33062187 10.1021/acsmedchemlett.0c00176 Unchecked 2
33684442 10.1016/j.bmcl.2021.127900 ADMET 2
- 10.6019/CHEMBL5724796 Bromodomain-containing protein 4 1
30769179 10.1016/j.ejmech.2019.01.043 Unchecked 1
- 10.6019/CHEMBL5724796 Transcription intermediary factor 1-alpha 1
- 10.6019/CHEMBL5724796 Peregrin 1
- 10.6019/CHEMBL5724796 Fibroblast growth factor receptor 2 1
- 10.6019/CHEMBL5724796 Tyrosine-protein kinase ABL1 1
- 10.6019/CHEMBL5724796 Aurora kinase A 1
- 10.6019/CHEMBL5724796 Mitogen-activated protein kinase 1 1
- 10.6019/CHEMBL5724796 Glycogen synthase kinase-3 beta 1
- 10.6019/CHEMBL5724796 Cyclin-dependent kinase 2 1
- 10.6019/CHEMBL5724796 Casein kinase I isoform delta 1
39142150 10.1016/j.ejmech.2024.116753 Solute carrier family 22 member 12 1
36335742 10.1016/j.ejmech.2022.114890 Broad substrate specificity ATP-binding cassette transporter ABCG2 1
33684442 10.1016/j.bmcl.2021.127900 Cytochrome P450 2C9 1

Data from ChEMBL 36 via Core Engine